$24.02
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Country

DE

CEO

Ms. Helen Giza

IPO date

1996

Employees

108,165

ISIN

DE0005785802

Key stats

Open

$24.07

Volume

388.74K

Market cap

$12.76B

Prev. close

$23.91

Impl / hst vl

-

Open interest

$0.00

$23.86

Day’s Range

$24.09

$20.02

52W Range

$24.71

Valuation

50
Valuation score
Fairly Valued
P/E
11.81
P/S
0.58
P/B
0.84
Current ratio
1.20
Debt / Equity
0.74
ROE
7.16%
Gross margin
25.57%
Income growth
-64.07%
FCF growth
-94.41

Jun

8

Dividends

The last payment date was Jun 8, 2026

Div. per Share

$0.99

Div. Yield

3.62%

Payout Ratio

-

Div. Growth YoY

6.93%

Analysts estimates

Consensus rating
Hold

The average rating from top 10 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$23.96
The top 22 analysts forecasts that 12-month price may decrease by 0.26%, with a low of $12.86 and a high of $35.55
$12.86
Low
$23.96
Avg
$35.55
High
Current price

Earnings

Q1 ‘26 revenue
$5.27B
Q1 ‘26 net income
$134.36M
Revenue
Net income
Previous EPS
$1.04
Estimate EPS
$1.18
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply